Top Midday Decliners
DocuSign's () revenue guidance for Q4 and full year fiscal 2022 came in lighter than expected as demand slowed after six quarters of acceleration, prompting the electronic signatures group to respond by investing aggressively in its salesforce.
Shares were down 41% by Friday afternoon as trading volume catapulted to more than 52 million from its daily average of 2.2 million.
Esperion Therapeutics () plunged 41% amid heavy trading volume after the company priced an offering of about 32.1 million shares and warrants at $7 each or about 22% below Thursday's closing price, targeting gross proceeds of about $225 million.
Net proceeds will be used to finance the ongoing commercialization of Nexletol and Nexlizet products as well as research and clinical development activities.
More than 17.4 million shares of the company were traded intraday compared with its daily average of 1.3 million.
Chindata () said Chief Executive Jing Ju is leaving with immediate effect and the search for its new CEO will also start immediately.
Shares of the data center service provide plunged 32%, with the volume of trading advancing almost four-fold to 7.6million.